Resmed (RMD) Long-Term Debt Issuances (2011 - 2023)

Resmed has reported Long-Term Debt Issuances for 13 years, with the latest figure at $105.0 million in Q3 2023.

• For the quarter ending Q3 2023, Long-Term Debt Issuances rose 110.0% year-over-year to $105.0 million; the trailing twelve-month figure through Jun 2024 stood at $105.0 million (down 90.19% YoY), and the FY2024 full-year result was $105.0 million, down 90.19% from the prior year.
• Long-Term Debt Issuances for Q3 2023 stood at $105.0 million, down from $1.0 billion in the prior quarter.
• The five-year high for Long-Term Debt Issuances was $1.0 billion in Q4 2022, with the low at $10.0 million in Q4 2021.
• Historically, Long-Term Debt Issuances has averaged $226.5 million across 5 years, with a median of $139.0 million in 2021.
• Annual changes were most pronounced in 2020 — Long-Term Debt Issuances plunged 90.27% — and 2022, when it jumped 10100.0%.
• Resmed's Long-Term Debt Issuances stood at $165.0 million in 2019, then slumped by 66.67% to $55.0 million in 2020, then slumped by 81.82% to $10.0 million in 2021, then jumped by 10100.0% to $1.0 billion in 2022, then plunged by 89.71% to $105.0 million in 2023.
• The last three Long-Term Debt Issuances figures came in at $105.0 million (Q3 2023), $1.0 billion (Q4 2022), and $50.0 million (Q3 2022), per Business Quant data.